TACSTD2 and posterior cortical atrophy: We also provide preclinical evidence that (iii) inversely correlated GSE1 and TACSTD2 expression patterns determine the survival of patients with PCa and that (iv) the GSE1 and TACSTD2 signal interplay affects the clinical and immune statuses and (v) determines the therapy responses and clinical outcomes in patients with PCa.